ACORDA THERAPEUTICS INC 4

4 · ACORDA THERAPEUTICS INC · Filed Nov 15, 2012

Insider Transaction Report

Form 4

Period: 2012-11-13

ACORDA THERAPEUTICS INCACOR

PANEM SANDRA PHD

Director

Transactions

Sale
Common Stock
2012-11-13$24.11/sh−1,282$30,909→ 2,912 total
Exercise/Conversion
Common Stock
2012-11-13$18.65/sh+1,287$24,003→ 4,199 total
Exercise/Conversion
Common Stock
2012-11-13$18.21/sh+10,000$182,100→ 14,199 total
Exercise/Conversion
Common Stock
2012-11-13$20.16/sh+10,000$201,600→ 24,199 total
Sale
Common Stock
2012-11-13$24.12/sh−21,287$513,442→ 2,912 total
Exercise/Conversion
Non-Employee Stock Option
2012-11-13−1,282→ 0 total
Exercise: $12.48Exp: 2013-03-06→ Common Stock (1,282 underlying)
Exercise/Conversion
Non-Employee Stock Option
2012-11-13−1,287→ 0 total
Exercise: $18.65Exp: 2016-12-01→ Common Stock (1,287 underlying)
Exercise/Conversion
Non-Employee Stock Option
2012-11-13−10,000→ 0 total
Exercise: $18.21Exp: 2017-08-06→ Common Stock (10,000 underlying)
Exercise/Conversion
Non-Employee Stock Option
2012-11-13−10,000→ 0 total
Exercise: $20.16Exp: 2018-05-21→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2012-11-13$12.48/sh+1,282$15,999→ 4,194 total

Footnotes (7)

[F1]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $24.10 to $24.14 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F2]Pursuant to a contractual arrangement between the reporting person and Cross Atlantic Partners, Inc., the reporting person disclaims beneficial ownership of these stock options and the corresponding 21,287 shares in the aggregate that were issued from the exercise of these options and were sold by the reporting person as reported on this form.
[F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $24.02 to $24.28 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F4]The shares subject to this option vested in equal annual installments on 3/6/2004, 3/6/2005, 3/6/2006, and 3/6/2007.
[F5]The shares subject to this option vested in equal quarterly installments on 3/1/2007, 6/1/2007, 9/1/2007, and 12/1/2007.
[F6]The shares subject to this option vested in equal quarterly installments on 9/5/2007, 12/5/2007, 3/5/2008, and 6/5/2008.
[F7]The shares subject to this option vested in equal quarterly installments on 8/21/2008, 11/21/2008, 2/21/2009, and 5/21/2009.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION